Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Stage IV Melanoma|Advanced Lung Cancer|Stage IV Non-Small Cell Lung Cancer|Unresectable Non-Small Cell Lung Carcinoma|Unresectable Stage III Non-Small Cell Lung Cancer|Small Cell Lung Cancer Extensive Stage|Stage IV Merkel Cell Carcinoma|Stage IV Cutaneous Squamous Cell Carcinoma|Stage IV Basal Cell Carcinoma|Stage IV Breast Cancer|Stage IV Colorectal Cancer|Stage IV Gastric Cancer|Stage IV Esophageal Cancer|Stage IV Hepatocellular Cancer|Stage IV Renal Cell Carcinoma|Stage IV Bladder Cancer|Stage IV Head and Neck Squamous Cell Carcinoma|Stage IV Cervical Cancer|Stage IV Endometrial Cancer|Stage IV Mesothelioma|Immunotherapy|Immune Checkpoint Inhibitors
Interventions: OTHER: Educational Video and QPL List|OTHER: Usual Care
Sponsor: Massachusetts General Hospital
Collaborators: Conquer Cancer Foundation